The Korea probiotic supplement industry is projected to expand at a CAGR of 11.6% through 2033. The demand for probiotic supplement in Korea is predicted to overgrow, reaching USD 241.03 million in 2023.
Growing public awareness of the significance of gut health, as well as increased demand for functional foods and dietary supplement, have all contributed to the industry expansion of probiotic supplement in Korea. The industry size of probiotic supplement in Korea is likely to be worth USD 722.70 million by 2033.
Key Highlights
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2023) | USD 241.03 million |
Anticipated Forecast Value (2033) | USD 722.70 million |
Estimated Growth (2023 to 2033) | 11.6% CAGR |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Attributes | Details |
---|---|
Bacteria Type | Lactobacillus |
Industry Share in 2023 | 36.3% |
Attributes | Details |
---|---|
End User | Women |
Industry Share in 2023 | 42.5% |
Industry players have employed various growth strategies to gain a competitive advantage, including capacity expansions, mergers and acquisitions, enhancing their online presence, and introducing new products. Some of the top Korean probiotic supplement firms include Cell Biotech, AceBiome, Amorepacific, Chong Dun Kang, Esther Formula, CJ Cheiljedang, and IIdong Pharmaceutical.
Innovations and creative approaches have benefited the probiotic supplement sector in Korea. Several product introductions in recent years have expanded the industry's client base while intensifying competition within the sector.
Recent Development in the Probiotic Supplement Industry in Korea
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Attribute | Details |
---|---|
Estimated Valuation (2023) | USD 241.03 million |
Projected Valuation (2033) | USD 722.70 million |
Anticipated CAGR (2023 to 2033) | 11.6% CAGR |
Historical Analysis of Probiotic Supplement in Korea | 2018 to 2022 |
Demand Forecast for Probiotic Supplement in Korea | 2023 to 2033 |
Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
Report Coverage | Industry Size, Industry Trends, Key Insights for Probiotic Supplement Adoption in Korea, Insights on Global Players and Leading Industry Strategy in Korea, Ecosystem Analysis of Local and Regional Industry. |
Key Companies Profiled | Cell Biotech; AceBiome; Amorepacific; Chong Dun Kang; Esther Formula; CJ Cheiljedang; IIdong Pharmaceutical |
The anticipated CAGR for the Korea probiotic supplement industry through 2033 is 11.6%.
Demand for probiotic supplement in Korea is likely to surpass USD 722.70 million by 2033.
In 2023, the industry size for probiotic supplement in Korea is valued at USD 241.03 million.
Lactobacillus are highly preferred in Korea, with an industry share of 36.3%.
In Korea, women consumers dominates the probiotic supplement industry with 42.5% industry share.
Estimated Market Size (2024E) | USD 7,524.6 million |
---|---|
Projected Market Value (2034F) | USD 23,874.5 million |
Value-based CAGR (2024 to 2034) | 11.2% |
Market Estimated Size (2023) | USD 26,543.0 million |
---|---|
Market Forecasted Size (2033) | USD 58,092.8 million |
Market CAGR (2023 to 2033) | 8.0% |
Market Size Value in 2022 | USD 394.1 Million |
---|---|
Market Forecast Value in 2032 | USD 566.7 Million |
Growth Rate (2022 to 2032) | 3.7% CAGR |
Explore Food Supplement and Nutrition Insights
View ReportsThank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.